# AplaGen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aplagen

- Industry: Biotechnology
- Headquarters: Baesweiler, Germany
- Total disclosed funding: $3.5M
- Latest round: Series B (Feb 1, 2006)
- Investors on record: 3

## About

AplaGen GmbH is a biopharmaceutical company which operates the development and commercialization of therapeutic peptides.

## Funding rounds

- Series B, Feb 1, 2006, $3.5M — Intelligent Venture Capital, NRW Bank, Capdura AG

## Investors

- Intelligent Venture Capital (https://capitalatlas.ai/funds/intelligent-venture-capital) — Series B
- NRW Bank — Series B
- Capdura AG — Series B